Cargando…

Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer

CONTEXT: Controversy surrounds the extent and intensity of the management of American Thyroid Association (ATA) intermediate- and low-risk patients with differentiated thyroid cancer (DTC). Understanding the natural history and factors that predict outcome is important for properly tailoring the man...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Ali S, Moria, Yosra, Mukhtar, Noha, Aljamei, Hadeel, Mazi, Sedra, Albalawi, Lina, Aljomaiah, Abeer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745668/
https://www.ncbi.nlm.nih.gov/pubmed/33367194
http://dx.doi.org/10.1210/jendso/bvaa178
_version_ 1783624651043241984
author Alzahrani, Ali S
Moria, Yosra
Mukhtar, Noha
Aljamei, Hadeel
Mazi, Sedra
Albalawi, Lina
Aljomaiah, Abeer
author_facet Alzahrani, Ali S
Moria, Yosra
Mukhtar, Noha
Aljamei, Hadeel
Mazi, Sedra
Albalawi, Lina
Aljomaiah, Abeer
author_sort Alzahrani, Ali S
collection PubMed
description CONTEXT: Controversy surrounds the extent and intensity of the management of American Thyroid Association (ATA) intermediate- and low-risk patients with differentiated thyroid cancer (DTC). Understanding the natural history and factors that predict outcome is important for properly tailoring the management of these patients. OBJECTIVE: This work aims to study the natural course and predictive factors of incomplete response to therapy in low- and intermediate-risk DTC. PATIENTS AND METHODS: We studied a cohort of 506 consecutive patients [418 women (82.6%) and 88 men (17.4%)] with low and intermediate risk with a median age of 35 years (interquartile range [IQR], 27-46 years). We analyzed the natural course and the predictive factors of biochemically or structurally incomplete response. RESULTS: Of 506 patients studied, 297 (58.7%) patients were in the low-risk group and 209 (41.3%) were in the intermediate-risk group. Over a median follow-up of 102 months (IQR, 66-130 months), 458 (90.5%) patients achieved an excellent response, 17 (3.4%) had a biochemically incomplete status, and 31 (6.1%) had a structurally incomplete status. In univariable and multivariable analyses, age (≥ 33 years) (P < .0001, odds ratio 1.06 [1.04-1.08]) and lateral lymph node metastasis (LNM; P < .0001, odds ratio 3.2 [1.7-5.9]) were strong predictive factors for biochemically and structurally incomplete response to therapy. Sex, tumor size, multifocality, extrathyroidal extension, and lymphovascular invasion did not predict incomplete response to therapy. CONCLUSIONS: Patients with low- and intermediate-risk DTC have favorable outcomes. Age and lateral LNM are strong predictors of an incomplete response to therapy. This suggests that older patients and those with LNM should be managed and followed up more actively than younger patients and those without LNM.
format Online
Article
Text
id pubmed-7745668
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77456682020-12-22 Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer Alzahrani, Ali S Moria, Yosra Mukhtar, Noha Aljamei, Hadeel Mazi, Sedra Albalawi, Lina Aljomaiah, Abeer J Endocr Soc Clinical Research Articles CONTEXT: Controversy surrounds the extent and intensity of the management of American Thyroid Association (ATA) intermediate- and low-risk patients with differentiated thyroid cancer (DTC). Understanding the natural history and factors that predict outcome is important for properly tailoring the management of these patients. OBJECTIVE: This work aims to study the natural course and predictive factors of incomplete response to therapy in low- and intermediate-risk DTC. PATIENTS AND METHODS: We studied a cohort of 506 consecutive patients [418 women (82.6%) and 88 men (17.4%)] with low and intermediate risk with a median age of 35 years (interquartile range [IQR], 27-46 years). We analyzed the natural course and the predictive factors of biochemically or structurally incomplete response. RESULTS: Of 506 patients studied, 297 (58.7%) patients were in the low-risk group and 209 (41.3%) were in the intermediate-risk group. Over a median follow-up of 102 months (IQR, 66-130 months), 458 (90.5%) patients achieved an excellent response, 17 (3.4%) had a biochemically incomplete status, and 31 (6.1%) had a structurally incomplete status. In univariable and multivariable analyses, age (≥ 33 years) (P < .0001, odds ratio 1.06 [1.04-1.08]) and lateral lymph node metastasis (LNM; P < .0001, odds ratio 3.2 [1.7-5.9]) were strong predictive factors for biochemically and structurally incomplete response to therapy. Sex, tumor size, multifocality, extrathyroidal extension, and lymphovascular invasion did not predict incomplete response to therapy. CONCLUSIONS: Patients with low- and intermediate-risk DTC have favorable outcomes. Age and lateral LNM are strong predictors of an incomplete response to therapy. This suggests that older patients and those with LNM should be managed and followed up more actively than younger patients and those without LNM. Oxford University Press 2020-11-11 /pmc/articles/PMC7745668/ /pubmed/33367194 http://dx.doi.org/10.1210/jendso/bvaa178 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research Articles
Alzahrani, Ali S
Moria, Yosra
Mukhtar, Noha
Aljamei, Hadeel
Mazi, Sedra
Albalawi, Lina
Aljomaiah, Abeer
Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
title Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
title_full Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
title_fullStr Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
title_full_unstemmed Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
title_short Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
title_sort course and predictive factors of incomplete response to therapy in low- and intermediate-risk thyroid cancer
topic Clinical Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745668/
https://www.ncbi.nlm.nih.gov/pubmed/33367194
http://dx.doi.org/10.1210/jendso/bvaa178
work_keys_str_mv AT alzahranialis courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer
AT moriayosra courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer
AT mukhtarnoha courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer
AT aljameihadeel courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer
AT mazisedra courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer
AT albalawilina courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer
AT aljomaiahabeer courseandpredictivefactorsofincompleteresponsetotherapyinlowandintermediateriskthyroidcancer